EverPulse was born from a simple but urgent belief: that the children who need the most advanced cardiac care shouldn’t have to wait for breakthroughs that already exist.
Congenital heart disease affects nearly 1 in 100 children born worldwide. Yet the pipeline from promising innovation to approved device remains slow, underfunded, and fragmented — especially for pediatric applications, where the commercial incentives are smaller and the regulatory path is harder.
EverPulse was created to change that. We sit at the intersection of funding, innovation, and advocacy — accelerating the development of life-saving technologies and connecting the people building them with the partners and resources they need to succeed.
We believe that every child deserves access to the best possible care. And we believe the technology to make that possible already exists, or soon will — if we fund it, support it, and fight for it together.
EverPulse accelerates innovation in pediatric heart care by funding and advancing life-changing medical technologies. Through strategic funding and partnerships, we ensure children with congenital heart disease gain access to life-saving solutions.
We provide strategic grants to researchers, startups, and medical technology developers working on solutions for pediatric cardiac patients. Our funding bridges the gap between early-stage innovation and clinical application — where most promising ideas stall.
We engage our community through comprehensive fundraising outreach efforts to raise funds that can help bring much-needed medical technologies to children with congenital heart disease.
We build relationships across the ecosystem to support innovators through the full development journey – from concept to clinical trial to market. We connect innovators with strategic advisors, clinicians, regulatory experts, and a network that opens doors because the best outcomes happen when the right people are working together.
Make a difference today
Help us fund the innovations that give children with congenital heart disease a fighting chance.
Follow us as we grow, and join us in changing the future of pediatric innovation, one pulse at a time.
